News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,904 Results
Type
Article (42289)
Company Profile (273)
Press Release (690326)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (205565)
Career Advice (2085)
Deals (35729)
Drug Delivery (129)
Drug Development (81812)
Employer Resources (173)
FDA (16593)
Job Trends (15087)
News (348113)
Policy (32924)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2616)
Accelerated approval (46)
Adcomms (27)
Allergies (168)
Alliances (49818)
ALS (203)
Alzheimer's disease (1770)
Antibody-drug conjugate (ADC) (429)
Approvals (16947)
Artificial intelligence (646)
Autoimmune disease (257)
Automation (52)
Bankruptcy (364)
Best Places to Work (11695)
BIOSECURE Act (20)
Biosimilars (218)
Biotechnology (183)
Bladder cancer (184)
Brain cancer (69)
Breast cancer (727)
Cancer (5685)
Cardiovascular disease (458)
Career advice (1771)
Career pathing (41)
CAR-T (319)
CDC (56)
Celiac Disease (3)
Cell therapy (850)
Cervical cancer (46)
Clinical research (70806)
Collaboration (2024)
Company closure (5)
Compensation (1339)
Complete response letters (79)
COVID-19 (2743)
CRISPR (106)
C-suite (1078)
Cystic fibrosis (150)
Data (7556)
Decentralized trials (3)
Denatured (27)
Depression (159)
Dermatology (76)
Diabetes (583)
Diagnostics (6955)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (275)
Earnings (91638)
Editorial (65)
Employer branding (21)
Employer resources (152)
Events (119885)
Executive appointments (1073)
FDA (20222)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (35)
Funding (1688)
Gene editing (228)
Generative AI (55)
Gene therapy (690)
GLP-1 (1040)
Government (4760)
Grass and pollen (6)
Guidances (403)
Healthcare (19072)
HIV (77)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (87)
Indications (175)
Infectious disease (3080)
Inflammatory bowel disease (206)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (285)
Interviews (332)
IPO (16706)
IRA (51)
Job creations (3708)
Job search strategy (1471)
JPM (59)
Kidney cancer (18)
Labor market (96)
Layoffs (570)
Leadership (38)
Legal (7994)
Liver cancer (99)
Longevity (32)
Lung cancer (756)
Lymphoma (422)
Machine learning (58)
Management (59)
Manufacturing (993)
MASH (179)
Medical device (13987)
Medtech (14084)
Mergers & acquisitions (20238)
Metabolic disorders (1469)
mRNA (196)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (399)
Neuropsychiatric disorders (103)
Neuroscience (3244)
Neurotech (1)
NextGen: Class of 2026 (6595)
Non-profit (4546)
Now hiring (76)
Obesity (684)
Opinion (287)
Ovarian cancer (208)
Pain (248)
Pancreatic cancer (288)
Parkinson's disease (354)
Partnered (34)
Patents (583)
Patient recruitment (649)
Peanut (61)
People (59712)
Pharmaceutical (59)
Pharmacy benefit managers (33)
Phase 1 (22110)
Phase 2 (31199)
Phase 3 (23209)
Pipeline (7922)
Policy (318)
Postmarket research (2573)
Preclinical (9404)
Press Release (65)
Prostate cancer (289)
Psychedelics (52)
Radiopharmaceuticals (319)
Rare diseases (1039)
Real estate (6007)
Recruiting (70)
Regulatory (25382)
Reports (55)
Research institute (2425)
Resumes & cover letters (359)
Rett syndrome (36)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (281)
Series B (209)
Service/supplier (11)
Sickle cell disease (109)
Special edition (26)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3672)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (87)
The Weekly (64)
Vaccines (1087)
Venture capital (103)
Weight loss (441)
Women's health (120)
Worklife (21)
Date
Today (197)
Last 7 days (761)
Last 30 days (2851)
Last 365 days (30569)
2026 (10599)
2025 (30527)
2024 (35537)
2023 (40267)
2022 (51357)
2021 (55882)
2020 (54262)
2019 (46797)
2018 (35188)
2017 (32503)
2016 (31786)
2015 (37756)
2014 (31477)
2013 (26509)
2012 (28716)
2011 (29408)
2010 (27465)
Location
Africa (762)
Alabama (92)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (39937)
Australia (6539)
California (12869)
Canada (3676)
China (1308)
Colorado (553)
Connecticut (567)
Delaware (389)
Europe (86569)
Florida (1927)
Georgia (414)
Hawaii (3)
Idaho (63)
Illinois (1045)
India (88)
Indiana (585)
Iowa (24)
Japan (513)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1552)
Massachusetts (9220)
Michigan (354)
Minnesota (701)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3467)
New Mexico (28)
New York (3377)
North Carolina (1660)
North Dakota (9)
Northern California (6405)
Ohio (379)
Oklahoma (23)
Oregon (41)
Pennsylvania (2592)
Puerto Rico (28)
Rhode Island (50)
South America (1142)
South Carolina (85)
South Dakota (2)
Southern California (5079)
Tennessee (207)
Texas (2036)
United States (45647)
Utah (383)
Vermont (1)
Virginia (312)
Washington D.C. (80)
Washington State (1030)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
732,904 Results for "x therma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Therma Bright Grants Stock Options
March 13, 2026
·
2 min read
Press Releases
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
January 20, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
Initial 200-Unit Sale previously announced on April 24, 2025, Targeted Specialized Knee Surgeons in U.S. Healthcare Network
September 24, 2025
·
4 min read
Press Releases
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
March 31, 2026
·
1 min read
Press Releases
X-Therma Welcomes Biotech Veteran Neil Warma to its Board of Directors
June 11, 2025
·
5 min read
Biotech Bay
X-Therma Achieves GMP Commercial Readiness with XT-Thrive®
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP commercial readiness with its flagship product, XT-Thrive®.
May 29, 2024
·
3 min read
Press Releases
Therma Bright Inc. Announces Share Consolidation
June 11, 2025
·
3 min read
Press Releases
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
February 10, 2026
·
1 min read
Press Releases
Therma Bright Proposes to Amend Certain Warrants
August 28, 2025
·
3 min read
1 of 73,291
Next
